Success is in the Air for Lou Bock

September 28th, 2009 |
Image for FaceBook
Download Audio FileRight click here to download audio | Share The Connected Social Media Player

 

It’s August 2009 and in the last 12 months, Lou Bock‘s portfolio has had some impressive success. He talks about how Zogenix, Horizon Therapeutics, Somaxon, Prestwick Pharmaceuticals and Orexigen have all done well. The Scale Venture Partners Managing Director has seen two positive Phase III outcomes, 2 FDA approvals and one progressing to approval since August 2008.

Share

Posted in: Venture Perspectives by Scale Venture Partners
Tags: , , , , , , , , ,

  1. No comments yet.
  1. No trackbacks yet.